Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuSepin in COVID-19 Pneumonia
NCT05352347Phase 3Unknown
- Sponsor
- Shaperon
- Start
- Apr 2022
- Primary completion
- Nov 2024
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hy209gel in COVID-19 pneumonia, sponsored by Shaperon. Status: unknown.
02
Drugs
hy209gel
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05352347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05352347.